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ABSTRACT The electrostatic environments near the acetylcholine binding sites on the nicotinic acetylcholine receptor (nAChR)
and acetylcholinesteraseweremeasured by diffusion-enhanced ﬂuorescence energy transfer (DEFET) to determine the inﬂuence
of long-range electrostatic interactions on ligand binding kinetics and net binding energy. Changes in DEFET from variously
charged Tb31-chelates revealed net potentials of 20 mV at the nAChR agonist sites and 14 mV at the entrance to the AChE
active site, in physiological ionic strength conditions. The potential at the ad-binding site of the nAChR was determined
independently in the presence of d-tubocurarine to be14mV; the calculated potential at the ag-site was approximately threefold
stronger than at the ad-site. By determining the local potential in increasing ionic strength, Debye-Hu¨ckel theory predicted that the
potentials near the nAChR agonist binding sites are constituted by one to three charges in close proximity to the binding site.
Examination of the binding kinetics of the ﬂuorescent acetylcholine analog dansyl-C6-choline at ionic strengths from 12.5 to 400
mM revealed a twofold decrease in association rate. Debye-Hu¨ckel analysis of the kinetics revealed a similar charge distribution as
seen by changes in the potentials. To determine whether the experimentally determined potentials are reﬂected by continuum
electrostatics calculations, solutions to the nonlinear Poisson-Boltzmann equation were used to compute the potentials expected
fromDEFETmeasurements from high-resolutionmodels of the nAChR andAChE. These calculations are in good agreement with
the DEFET measurements for AChE and for the ag-site of the nAChR. We conclude that long-range electrostatic interactions
contribute 0.3 and 1 kcal/mol to the binding energy at the nAChR ad- and ag-sites due to an increase in association rates.
INTRODUCTION
Neuromuscular junction signal transduction involves the
rapid binding of acetylcholine (ACh) to the nicotinic
acetylcholine receptor (nAChR) followed by rapid clearance
of ACh from the synapse by acetylcholinesterase (AChE)
catalyzed hydrolysis. The ACh binding sites of both of these
proteins are located within deep clefts, yet association with
both proteins occurs at or near diffusion limited rates. One
mechanism that may enhance the rate of cationic ligand
binding to these proteins is long-range electrostatic attraction
toward negatively charged surfaces near the ligand binding
sites. Such electrostatic steering has been proposed as a
mechanism for accelerating the rate of ligand association at
the active site of AChE by concentrating the cationic ligands
near the active gorge with an electronegative ﬁeld (1,2).
Early estimates using Brownian dynamics placed the mag-
nitude of electrostatic steering as high as a 40-fold increase in
association rates (2). Subsequent computational reﬁnements
lowered this estimate to an increase of two- to sixfold (3),
depending on ionic strength. These changes were consistent
with the rates of binding of variously charged ligands upon
successive mutagenesis of negatively charged surface resi-
dues on AChE (4).
The protein surfaces near the agonist binding sites of the
nAChR have also been shown to be negatively charged: a
local potential of80 mVwas measured in low ionic strength
using the substituted cysteine accessibility method (5), and
a potential of 15 mV was measured in physiological ionic
strength using electron paramagnetic resonance (6). The
binding afﬁnity of the ﬂuorescent agonist dansyl-C6-choline
(DC6C) appears to be inﬂuenced by the electrostatic en-
vironment of the nAChR through two mechanisms. Direct
electrostatic interactions that enhance binding of the ligand to
the desensitized agonist site and indirect electrostatic interac-
tions that affect the equilibrium between the resting and
desensitized conformational states of the nAChR (7). The
intrinsic decrease in desensitized-state afﬁnity with increased
ionic strength is about threefold (7). Raising ionic strength
does not inﬂuence agonist dissociation kinetics at the ad-site,
but decreases the dissociation rate by twofold at the ag-site.
The increased afﬁnity and faster dissociation rate in low ionic
strength at the ag-site suggests that its association rate should
be faster than the association rate for the ad-site; in phys-
iological ionic strength, however, the association rates are
indistinguishable between the two sites (8).
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The quaternary ammonium common to nAChR agonists
and to many antagonists is stabilized predominantly by in-
teractions with aromatic p-electrons and not by direct charge
neutralization or ion pair formation (9–11). However, the
structure of the nAChR determined by electron-microscopic
imaging of tubular crystalline arrays shows that anionic
amino acids are concentrated near the agonist binding sites,
with more negative charges present near the ag-site than
the ad-site (12). This suggests a role for the surrounding
negative charges in accelerating the rate of agonist binding,
particularly at the ag-site at low ionic strength.
In the accompanying articles, the electrostatic environ-
ment within the ion-conductive pore of the nAChR was
determined experimentally using diffusion-enhanced ﬂuo-
rescence energy transfer (DEFET) (13). We further took ad-
vantage of the well-developed theoretical basis of DEFET to
compute expected changes in DEFET from the computed
electrostatic potential (14–19). A direct comparison of ex-
perimentally determined potentials and the expected results
from computed potentials revealed a consistent twofold or
higher overestimate of computed potentials compared to the
measured potentials. Although the exact basis of this dis-
crepancy is unknown, it may reﬂect the limitations of contin-
uum electrostatics computations in the constricted, concave
environment of the nAChR channel where the charged
residues are in close apposition to the ﬂuorescence energy
transfer acceptor (20). In contrast the ACh binding site en-
trances of AChE and the nAChR reside on a typically convex
protein surface surrounded by negative surface charges.
In this article we apply the DEFET method to determine
the contribution of the local potentials about the binding sites
of the nAChR and AChE to agonist association rates and
binding energies using ﬂuorescent analogs as the DEFET
acceptors. Experimental results were consistent with the po-
tentials predicted by computational simulations. In addition,
stopped-ﬂow kinetic measurements of DC6C binding to the
nAChR were used to determine the effect of electrostatic
potentials on association rates. The data are consistent with a
two- to threefold effect of long-range electrostatic attraction
on association rates and binding constants.
MATERIALS AND METHODS
Materials
Dansyl-C6-Choline (DC6C) was synthesized as described previously (7,21).
N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-5-acylcholine (NBD-5-AC) was syn-
thesized as described by Jurss et al. and Meyers et al. (22,23). Decidium, a
bis-quaternary ethidium bromide analog with a 10-carbon methonium at-
tachment (see Fig. 1) was synthesized as described by Berman et al. (24).
m-Aminophenyl-trimethylammonium was synthesized according to Berman
and Young (25). The luminescent terbium chelates, Tb31-EDTA ammonium
(Tb), Tb31-N-(2-hydroxyethyl)ethylenediamine triacetate (Tb0), and Tb31-
N,N9-bis-(2-hydroxyethyl)ethylenediamine diacetate, bicarbonate (Tb1) were
prepared as described (13). All compounds synthesized within the lab had
the expected properties as characterized by mass spectroscopy, absorbance
spectra, ﬂuorescence spectra, and, where appropriate, by binding to their
targets.
nAChR and AChE were puriﬁed from Torpedo californica electric organ.
nAChR enriched membranes were prepared as described (26,27). AChE was
puriﬁed essentially as described by Taylor et al. (28): AChE was cleaved
FIGURE 1 Fluorescent ligand structures. (A) NBD-5-AC is shown
schematically and as a heavy-atom van der Waals structure as bound at
the nAChR ag-agonist binding site. The a-subunit is blue, the g-subunit
green; the other subunits were omitted for clarity. (B) Decidium is shown
schematically and as bound to the Torpedo californica AChE catalytic site
entrance. Structures and docking of ligands were determined as described in
Materials and Methods.
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with trypsin from crude Torpedo membranes, retained from the initial low-
speed centrifugation step (26,27), and then puriﬁed by afﬁnity chromatog-
raphy using m-aminophenyl-trimethylammonium as the afﬁnity ligand
(25,28). Typical protein yield was 5–15 mg per preparation. AChE was pure
as assessed by SDS-polyacrylamide gel electrophoresis (29) and by
enzymatic activity measured using the Ellman assay (30).
Spectral and lifetime measurements
Tb31-chelate spectra were measured as described previously (13). Absor-
bance spectra of 400 nM NBD-5-AC or decidium in the presence of 500 nM
nAChR or AChE, respectively, were measured on a Cary 1/3 UV/VIS
spectrophotometer (Varian, Sugarland, TX) in dual beam mode against
reference samples without ﬂuorophores. The R0 values for energy transfer
from Tb31-chelates to NBD-5-AC and to decidium were determined as
described for crystal violet in Meltzer et al. (13).
Lifetime determinations were carried out on a PhosphoCube lifetime
instrument from HORIBA Jobin Yvon IBH or on an instrument using a
mechanically chopped argon-ion laser as the excitation source, as described
(13,31). Time-correlated photon counting of emitted light was collected
through a 545-nm bandpass ﬁlter to monitor the peak Tb31 emission.
DEFET of Tb31-chelates to NBD-5-AC was measured in 10 mM HEPES,
pH 7.0, in HTPS (250 mM NaCl, 5 mM KCl, 3 mM CaCl2, 2 mM MgCl2,
20 mMHEPES, pH 7.0), or in 300 mMNaCl, 10 mMHEPES, pH 7.0. Some
experiments were performed with buffers prepared in D2O to increase the
Tb31-chelate lifetimes. NaCl titrations were performed in 25 3 5 3 5 mm
stoppered glass cuvettes (Starna, Essex, England) by addition of 3 or 5 M
NaCl in 10 mM HEPES, pH 7.0. All buffers were titrated to pH 7.0
immediately before the experiments and kept under argon to prevent ex-
change with atmospheric moisture.
DEFET measurements of electrostatic potential were performed by
determining the second order rate constants of energy transfer, k2 ; k
0
2 , and k
1
2 ,
from the changes in lifetimes of the variously charged Tb31-chelates, Tb,
Tb0, and Tb1, with the addition of acceptor. kx2 values, where x indicates the
chelate charge, were calculated from either a single acceptor concentration or
from the slope of a serial titration of NBD-5-AC into the nAChR as described
previously (13): kx2 ¼ ðkobs  k0Þ= ½NBD 5 AC or kobs ¼ kx2 ½NBD
5 AC1 k0 where kobs ¼ 1/tobs. Samples often had a signiﬁcant concen-
tration of free, unboundNBD-5-AC that contributed to the DEFET signal. To
correct the signal for unbound NBD-5-AC, its concentration was measured
from the ﬂuorescent intensity of samples and comparison to a standard curve,
after clearing bound NBD-5-AC by centrifugation in a TOMY 150 MTX
bench-top microcentrifuge. Energy transfer rates for bound NBD-5-ACwere
adjusted for the contribution of free NBD-5-AC as follows:
k2adj ¼ k2obs  ½NBDfree=½NBDtotal  kfree
1 ½NBDfree=½NBDtotal : (1)
The values for kxfree were determined independently for each chelate.
To distinguish the local potentials at the ag- and ad-sites, 5 mM
d-tubocurarine was added to speciﬁcally block the ag-site. Lifetime mea-
surements at the ad-site were then recorded in the presence or absence of
1 mM NBD-5-AC. The energy transfer rate kx2 for each of the Tb
31-chelates
was computed for the ag-site (kx2ag) from the experimentally determined
rates for the whole receptor (k2total) and the ad-site (k2ad):
k2ag ¼ 2  k2total  k2ad: (2)
The electrostatic potential about the acceptor ﬂuorophore was calculated
from the energy transfer rates k2 ; k
0
2 , and k
1
2 as described (13), using ratios
(c ¼ kBT lnðk12 =k02Þ=e) or the slope of ln(kx2) versus charge (c ¼ ðkBT=eÞ 
ðslope of lnðkx2ÞÞ); the slope is determined by linear regression. Errors in kx2
values were the mean6 SE of several separate experiments; the error for the
corresponding potential c (sc) was determined by propagation of errors
(13). Charge number (z) and the mean distance of closest approach between
charges and counterions (r) near the nAChR agonist binding site were
estimated by ﬁtting changes in potential with ionic strength to the Debye-
Hu¨ckel equation, Eq. 3.
cðIÞ ¼ zqeekr=4pee0r 1
k
¼ ee0RT
2F
2
 0:5
I
0:5
: (3)
The potential at a given ionic strength c(I) is a function of the elementary
charge qe, the polarizability of free space, e0, the dielectric constant, e, and
the Debye length 1/k. The Debye length characterizes the screening effect of
ionic strength on potential experienced about a point charge where R is the
gas constant, F is Faraday’s constant, and I is the ionic strength (for details
also see Eq. 6 in Meltzer et al. (13)).
For experiments to determine the potential at the AChE active site,
lifetime determinations were carried out in 1 mM Tris, pH 8.0, 10 mM Tris,
pH 8.0, or in 40 mM MgCl2, 100 mM NaCl, 10 mM Tris, pH 8.0. Tb
31-
chelate concentrations were 4 or 8 mM; AChE concentrations were 10 or
20 mM; decidium was titrated into samples in concentrations ranging from 0
to 10 mM. Luminescent decay rates (kobs) were determined at each concen-
tration and the rate constant for energy transfer, kx2 , determined from the
slope of kobs versus decidium concentration as described above; only data up
to 4.5 mM decidium was included because higher concentrations displayed
deviations consistent with the presence of free decidium. Potentials were
computed from matched titrations of the three chelates using the slope of
ln(kx2) versus charge (13). The errors of the k
x
2 and the electrostatic potentials
are the averages and ranges of several individual experiments.
Computational modeling
The atomic-resolution homology structure of the nAChR described in the
accompanying article (14) was used to model the binding of NBD-5-AC.
The quaternary ammonium of NBD-5-AC was positioned in the nAChR
ag- and ad-binding sites according to the position of the carbamylcholine
ammonium in the structure of AChBP and then energy minimized using the
MM1 parameter set implemented in Hyperchem (vs. 5.1, Hypercube,
Gainesville, FL). The crystallographic coordinates of decidium bound to the
mouse AChE (accession No. 1JO7) (32) were transferred into the structure
of Torpedo AChE. (NCBI accession No. 1EA5 (33)). As the residues in the
vicinity of decidium are identical in mouse and TorpedoAChE, the resulting
decidium-bound structure was used without further reﬁnement.
Computational methods for assigning partial charges, determining
electrostatic potentials, and computing DEFET rates were applied essentially
as described (14). The charge distribution of decidium and NBD-5-AC were
determined by semiempirical quantum mechanics in Hyperchem using
the AM1 Hamiltonian. Protein partial charges were assigned using the
University of Houston Brownian dynamics program (UHBD) implementa-
tion of the Bashford and Karplus method (34). The electrostatic potentials
were computed with UHBD at 20 mM or 300 mM ionic strength using the
nonlinear Poisson-Boltzmann equation (35). Several iterations were carried
out using decreasing grid sizes with the boundary conditions deﬁned from
the previous iterations. This produces a grid in the vicinity of the binding site
with sufﬁcient resolution for computation of kx2 values without loss of long-
range electrostatic information.
The bimolecular rate constants (kx2) for DEFET from charged Tb
31-
chelates were computed by numerical integration (15) over a 65 3 65 3 65
point grid that was spaced at 0.75 A˚ and centered on the acceptor
chromophore. The chelate radius was assumed to be 5 A˚. The distance to the
acceptor ﬂuorophore was measured from the chelate center to the nearest
atom in the chromophore of either NBD-5-AC or decidium. The integration
included the electrostatic effects of the Poisson-Boltzmann calculation on
the local chelate concentration (see Eq. 7 in Meltzer et al. (14)) for each
chelate. These kx2 values, in turn, can be used to compute a potential in the
same manner as for experimental kx2 values, and provides a point of direct
comparison between experimentally determined and computed potentials.
Directly comparing the kx2 values is impractical because the numerical
integration is highly sensitive to assumptions of chelate radius and other
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factors. These factors tend to cancel upon calculating a potential from the
ratio of kx2 values. The potential is, therefore, a more robust point of
comparison (14). Direct comparison of the Poisson-Boltzmann calculation
with the potentials from experimental kx2 measurements may be misleading
because the kx2 values reﬂect an integrated effect of the potential over the
volume where energy transfer can occur and, thus, does not correspond
directly to any single potential value.
nAChR binding assays
NBD-5-AC binding to nAChR membranes was measured by inhibition of
the initial rate of 125I-a-Bungarotoxin binding, essentially as described (36).
nAChR was ﬁrst treated with diisopropyl ﬂuorophosphonate (Aldrich
Chemical, Milwaukee, WI) to inactivate AChE. Binding was for 45 min in
1 nM 125I-a-Bungarotoxin in HTPS buffer and with varying concentrations
of NBD-5-acylcholine. The reactions were quenched by the addition of 300
nM a-bungarotoxin, ﬁltered, and counted. IC50s were determined by ﬁtting
to a single site inhibition curve (37).
DC6C association kinetics were determined by ﬂuorescence enhance-
ment upon binding, using energy transfer from nAChR tryptophan residues,
after rapid mixing on a model SF-2001 stopped-ﬂow instrument from Kintek
(Austin, TX) (8). Kinetics were determined in 20 mMHEPES at pH 7.0 with
varying NaCl concentrations, in the presence or absence of 10 mM
proadifen. Fluorescence was excited at 290 nm with a 4-nm slit width using
a 75W xenon lamp; emission was measured through a 495-nM cut-on ﬁlter
(Oriel 59492). Kinetic traces were ﬁtted to a three exponential equation:
F ¼ A1ek1t1A2ek2t1A3ek3t1C; (4)
where F is the observed ﬂuorescence intensity, k1, k2, and k3 are the rate
constants of the fast, intermediate, and slow association components, and A1,
A2, and A3 are their respective amplitudes. C represents the background
ﬂuorescence. The ionic strength dependence of the fast association rate was
analyzed using an equation derived from Debye-Hu¨ckel theory, Eq. 5, (7,38)
to estimate the number (zR) and mean distance of closest approach of charges
(r) near the ACh binding sites.
logk ¼ logk0  ð2AzRzLI0:5Þ=ð11 rBI0:5Þ: (5)
RESULTS
Electrostatic steering is a mechanism for enhancing the
binding rate and afﬁnity of ionic ligands by a distribution of
counter charges that evoke an attractive potential ﬁeld. One
of the best characterized examples of electrostatic steering is
the binding of ACh to AChE, and this mechanism may also
serve to enhance ACh-binding to the nAChR. To determine
the contribution of electrostatic potentials to nAChR-binding
energy and kinetics, we ﬁrst determined the electrostatic
potentials at the sites by diffusion-enhanced ﬂuorescence
energy transfer (DEFET). We also determined the potential
at the AChE active-site entrance by DEFET measurements to
correlate experimental potentials with the extensive extant
enzymatic and computational work on AChE.
Applying the DEFET approach required energy transfer
acceptors located at these sites. NBD-5-AC is a high-afﬁnity
nAChR agonist that has spectral overlap with Tb31-emission
(22,23). We modeled the binding of this ligand to the
Torpedo AChR on the basis of the crystal structure of
carbamylcholine bound to AChBP as described in Materials
and Methods (Fig. 1 A). The NBD ﬂuorophore was localized
to solvent-exposed regions at the ACh-binding site en-
trances. The high-afﬁnity, bis-quaternary, AChE inhibitor
decidium binds near the entrance to the mouse AChE active
site (32). A model for decidium bound to Torpedo AChE
(Fig. 1 B) was constructed by combining the crystal struc-
tures of Torpedo AChE and of decidium bound to the mouse
AChE. After synthesizing NBD-5-AC and decidium, their
energy transfer parameters as acceptors of Tb31-chelate lu-
minescence were characterized.
Energy transfer efﬁciency of donor-acceptor pairs
The efﬁciency of energy transfer between two ﬂuorophores is
characterized by the Fo¨rster distance (R0), the distance atwhich
energy transfer is 50% efﬁcient. R0 was computed from the
optical properties of Tb1, Tb0, and Tb as the energy transfer
donors and NBD-5-AC and decidium as acceptors (Table 1).
The spectral overlap integral J represents the overlap of donor
luminescence emission spectrumwith the acceptor absorbance
spectrum and is required to determine R0; these spectra are
shown in Fig. 2. Notably, the spectrum for decidium bound to
AChE is shifted 20 nM to the red comparedwith free decidium
(not shown). The R0 values for the donor-acceptor pairs are
;33 A˚ for energy transfer toNBD-5-AC and;31 A˚ for Tb31-
chelate energy transfer to bound decidium. The R0 values for
free decidiumare near 28 A˚ (data not shown). The uncertainties
listed in Table 1 are due to the possible variation in the dipole
orientation factor k2. The R0 values were utilized primarily for
numerical integration of the DEFET rates, kx2; k
2 values were
computed explicitly at each grid point in the computation,
thereby eliminating the effect of the uncertainty in R0 on the
integrated result.
Local electronegative potentials at the nAChR
agonist sites
We ﬁrst determined the binding afﬁnity of NBD-5-AC for
the nAChR so that we could design the experimental
TABLE 1 Fluorescence energy transfer parameters
Tb1 Tb0 Tb
h 1.33
k2 1/3–4/3
Q0 0.182 0.187 0.224
NBD-5-AC
J (M1cm3)* 3.80 3 1014 3.75 3 1014 3.83 3 1014
R0
y (A˚) 33.2 6 5.4 33.2 6 5.4 34.9 6 5.7
Decidium
J (M1cm3)* 2.36 3 1014 2.34 3 1014 2.29 3 1014
R0
y (A˚) 30.6 6 5. 30.7 6 5. 32. 6 5.
*The values J, Q0, h, and k
2 were determined as described in Materials and
Methods; values for J were computed from the spectra of the bound ligand
determined in water.
yR0 was computed for the minimum and maximum values of k
2; the
average and range are presented.
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conditions to minimize the free ligand concentration and the
energy transfer to unbound NBD-5-AC. A KD of 336 3 nM
was determined by inhibition of the initial rate 125I-a-
Bungarotoxin binding to the nAChR in HTPS; in the
presence of 25 mM tetracaine, the KD was 476 4 nM; in the
presence of the desensitizing noncompetitive antagonist
proadifen, the KD was 15.4 6 2.7 nM.
The electrostatic potentials at the agonist binding sites of
the Torpedo californica nAChR were determined from the
changes in DEFET rates, k12 ; k
0
2, and k

2 , to bound NBD-5-
AC with the change in charge of the three corresponding
Tb31 chelates, Tb1, Tb0, and Tb. The observed DEFET
rate is measured from the changes in luminescent decay rate
in the absence and presence of acceptor, as shown in Fig. 3 A.
The change in decay rate is proportional to the acceptor
concentration and higher concentrations yield more robust
changes. Reliable determinations of DEFET rates required
mM concentrations of free NBD-5-AC; therefore, DEFET
measurements to bound NBD-5AC required similar or
higher nAChR concentrations. To improve sensitivity and
to minimize artifacts from the strongly scattering membrane
suspension, we carried out experiments in D2O, rather than
H2O (39). This is shown in Fig. 3 A where decays in the
presence and absence of 3 mM NBD-5-AC are compared for
H2O and D2O. Experiments in D2O had lifetimes about three
times longer than in H2O and had greater changes in decay
rate at the same NBD-5-AC concentration. DEFET rates (kx2)
are independent of chelate lifetime and we could, therefore,
combine kx2 data from experiments carried out in either H2O
or in D2O.
The electrostatic potential for freeNBD-5-ACas calculated
from DEFET rates k12 , k
0
2, and k

2 , indicated a local potential
of 5.1 mV in low ionic strength solution (Table 2). This value
is smaller than that observed for free crystal violet (13), for
ethidium (17), or for decidium (see below), but can be
explained by the distance between the ﬂuorophore and the
cationic center in NBD-5-AC (see Fig. 1 A), unlike the other
acceptors where the cation is integral to the ﬂuorophore. The
potential at the nAChR agonist sites was determined from the
FIGURE 2 Spectral overlap of Tb emission with decidium and NBD-5-
AC absorbance. The emission spectrum of 1 mM Tb (solid line) was
measured with excitation at lex ¼ 370 nm. Absorbance spectra were
measured for 400 nM NBD-5-AC bound to nAChR (500 nM, dashed line)
and for 2.1 mM decidium bound to 5 mMAChE (dotted line) as described in
Methods and Materials; extinction coefﬁcients were calculated from the
measured absorbance and the ﬂuorophore concentration.
FIGURE 3 D2O enhances Tb
31-chelate lifetimes. (A) Luminescence
decays of 1 mM Tb0 were measured as described in Materials and Methods
in the absence (d, n) or presence (s, h) of 3 mM NBD-5-AC in 10 mM
HEPES prepared in D2O (s, d) or H2O (h, n). (B, C, D) Energy transfer
from Tb31-chelates to NBD-5-AC bound to nAChR. The luminescence
decays (kobs) of (B) Tb
1 (:,n), (C) Tb0 (d,s), and (D) Tb (;,n) were
measured in 10 mM HEPES, (:, d, ;) or in 10 mM HEPES, 300 mM
NaCl (n,s,,) prepared in D2O. Measurements were made in the presence
of 2 mM nAChR agonist binding sites with or without 1 mM NBD-5-AC, in
paired samples. Note the changes in scale among B, C, andD. Errors bars are
the mean 6 SE of n ¼ 3 samples.
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k12 ; k
0
2, and k

2 values calculated from decay rates taken in
the absence or presence of 1mMNBD-5-AC as shown in Fig.
3 B. These values were further corrected for energy transfer to
residual free NBD-5-AC using Eq. 1. The free NBD-5-AC
concentration was determined from ﬂuorescence of the
sample after clearing bound NBD-5-AC by centrifugation
andwas routinely,10%. The corrected values for k12 ; k
0
2, and
k2 are summarized in Table 2. The binding sites have a net
potential of38 mV in low ionic strength that is decreased to
22mV in physiological ionic strength buffer. The change in
k02 values from free to boundNBD-5-AC indicates the relative
accessibility of the ﬂuorophore upon binding; this was only a
50% decrease, indicating that the bound NBD ﬂuorescent
group remains largely solvent accessible, an observation that
is consistent with the structural model in Fig. 1 A.
Agonists bind cooperatively to the nAChR, and therefore,
we would expect the ag- and ad-sites to be equally occupied
by NBD-5-AC during the DEFET experiments described
above (8). Thus, the measured potential should reﬂect con-
tributions from both sites. To determine whether the elec-
trostatic potential differed signiﬁcantly between the two
sites, we determined the DEFET rates at the ad-site by
selectively blocking the ag-binding site with d-tubocurarine
(40,41). From the DEFET measurements taken at the ad-site
and at both sites, the energy transfer rates and local potentials
at the ag-binding site were calculated as described in
Materials and Methods (Eq. 2). The data in Table 2 show a
substantially smaller potential at the ad-site in both high and
low ionic strength buffers. The calculated kx2 values and
voltage at the ag-site are concomitantly larger in magnitude.
These data suggest that most of the observed net potential
was derived from the ag-site, 60 mV in low ionic strength
and 43 mV in physiological ionic strength.
Computational simulation of agonist site
electrostatic potentials
To determine whether these measured potentials were
consistent with computed potentials, we computed Pois-
son-Boltzmann electrostatic surface potentials from the struc-
tural models of NBD-5-AC bound to the nAChR ag- and
ad-agonist binding sites and of free NBD-5-AC using the
UHBD program. The computed potentials were then used to
calculate the expected DEFET rates for each ACh binding
site by numerical integration of the DEFET equation as de-
scribed in Materials and Methods and in Meltzer et al. ((14);
Eq. 7). This approach directly compared computed and ex-
perimental DEFET rates and potentials. As observed previ-
ously (14), the computed DEFET rates were sensitive to the
values assumed for several parameters, such as chelate size.
Nonetheless, the voltages calculated from the rates were
relatively robust because these parameters affected all three
chelates in a systematically similar way and the effects can-
cel when computing the potential (42). Here, we assumed a
chelate radius of 5 A˚, which is close to the value obtained
from molecular modeling of the chelates.
TABLE 2 Energy transfer and local potential determined near NBD-5-AC and the nAChR agonist binding sites
Experimental kx2 (mM
1 s1)*
I (mM) k12 k
0
2 k

2 c (mV)
y
NBD-5-AC 6 25.3 6 1.1 (3) 29.8 6 1.0 (3) 37.8 6 1.2 (3) 5.1 6 0 .9
nAChR 6 57.0 6 2.9 (7) 11.7 6 0.5 (8) 2.9 6 0.4 (8) 37.9 6 2.1
ad-sitez 6 38.8 6 1.1 (5) 14.9 6 0.6 (5) 5.1 6 1.0 (5) 25.7 6 2.5
ag-site (calculated) 6 75.2 6 1.4 8.4 6 0.8 0.6 6 0.4 60.4 6 8.8
nAChR 300 35.5 6 1.1 (6) 13.5 6 0.6 (6) 6.1 6 0.4 (6) 22.4 6 1.2
ad-sitez 300 33.2 6 2.2 (4) 14.3 6 0.7 (4) 10.9 6 0.9 (4) 14.2 6 1.6
ag-site (calculated) 300 37.7 6 2.4 12.7 6 0.9 1.3 6 1.0 42.7 6 10.0
Computed kx2 (mM
1 s1)§
I (mM) k12 k
0
2 k2
 c (mV)y
NBD-5-AC 20 13 15.6 19.8 5.3
nAChR 20 24.5 3.6 1.4 36.3
ad-site 20 8.6 4.3 2.5 15.7
ag-site 20 40.3 2.9 0.3 62.2
nAChR 300 6.6 3.6 2.6 12.1
ad-site 300 5.2 4.3 3.9 3.7
ag-site 300 8 2.9 1.2 24.5
*kx2 values were determined from Tb
31-chelate lifetime determinations in 3 mM nAChR suspensions, before and after addition of 1 mM NBD-5-AC, as
described in Materials and Methods; the values were corrected for free NBD-5-AC.
yLocal potentials were computed from experimental or computed k2
x values and the corresponding errors determined by propagation of errors.
zkx2 values for the ad-site were determined from samples including 5 mM d-tubocurarine to block the ag-site.
§Computed kx2 values were determined from the structure of NBD-5-AC alone or bound to either the ag-site or ad-site. The nAChR k2
x values were computed
from the average of both kx2 values.
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The computed DEFET rates and the corresponding
voltages as calculated from the ratios of the DEFET rates
are given in Table 2. The computed k02 value for free NBD-5-
AC was twofold lower than the experimental k02, indicating
that the integration yielded a reasonable approximation for
the simplest case of free acceptor, without charge effects, and
in the absence of protein. The corresponding voltage of
5.3 mV agrees closely with the experimental value, 5.1 mV,
further substantiating the validity of the integration. For
nAChR-bound NBD-5-AC, computed k02 values were up to
fourfold lower than the corresponding experimental values.
Comparing k02 values for free NBD-5-AC to bound NBD-5-
AC (k02free :k
0
2bound) indicates the extent of shielding of the
ﬂuorophore from solvent. Comparison of the experimental
k02 values shows this ratio to be ;2.5; the computed values
yield a ratio of ;4.3, indicating that the structural binding
model somewhat overestimates the extent of shielding of the
chromophore.
The potentials calculated from the computed k2 , k
0
2, and
k12 values for low ionic strength show good agreement with
the experimental values for the ag-site and for the net
potential, whereas the ad-site potential is underestimated by
40%. For high ionic strength, the discrepancies are larger; the
computed values underestimated experimental potentials
twofold or more. Comparison of the computed potentials at
low and high ionic strength show stronger screening by ionic
strength than occurs experimentally. At physiological ionic
strength, the computational and experimental determinations
of kx2 values suggest that the protein surface charge dis-
tribution contributes a two- to ﬁvefold increase in the local
cation concentration at the ag-site and very little increase at
the ad-site.
Charge number and distribution from ionic
strength perturbation
An alternative approach to analyzing the electrostatic
environment of the agonist binding sites is to determine the
variation of the potential with ionic strength. DEFET rates
were measured during titration of increasing NaCl concen-
trations for NBD-5-AC in the presence or absence of excess
nAChR for each of the three Tb31-chelates (Fig. 4). The
energy transfer rates k12 , k
0
2, and k

2 are shown for NBD-5-
AC free in solution (Fig. 4 A) and bound to the nAChR (Fig.
4 B). The inﬂuence of the negative potentials near the agonist
sites is apparent from the larger difference between k12 and
k2 for bound NBD-5-AC as compared with free NBD-5-AC.
The local potentials at each ionic strength condition were
computed from ratios of the rates and plotted versus ionic
strength in Fig. 4 C. Fits of the Debye-Hu¨ckel equation (Eq.
3) to the potential estimates the number and distribution of
charged amino acids near the site of NBD-5-AC binding.
Best ﬁts of Eq. 3 to free NBD-5-AC-potentials gave z ¼
0.136 0.03 and r¼ 4.46 0.7 A˚. For bound NBD-5-AC, z¼
0.74 6 0.2 and r ¼ 3.1 6 0.7 A˚ (see Table 4).
The inﬂuence of the charge distribution on agonist
binding kinetics
To evaluate the effect of long-range electrostatic attraction
on the kinetics of binding, we determined the association
rates for the ﬂuorescent agonist DC6C in varying ionic
strengths. When the nAChR is rapidly mixed with DC6C in
the stopped-ﬂow, binding kinetics in high ionic strength are
dominated by slow conformational changes that can be ﬁtted
to three exponentials (see Fig. 5 A, right trace). The fastest
exponential component corresponds to direct binding to
preexisting desensitized receptors; it reﬂects the intrinsic
association rate and is the rate of interest. At the highest ionic
strength, this component is a small fraction (5–20%) of the
total ﬂuorescence change; however, as the ionic strength
decreases, more receptors preexist in a desensitized state and
the amplitude of this fast component is increased and the
association trace appears shifted to the left (Fig. 5 A). Bind-
ing kinetics were also measured in the presence of 10 mM
FIGURE 4 NaCl screens the electrostatic potential at nAChR agonist
sites. Energy transfer rates (kx2) were calculated from luminescent decay rates
for Tb1 (n), Tb0 (s), and Tb (,) determined in the absence or presence of
1 mM NBD-5-AC. Measurements were made for NBD-5-AC either (A) free
or (B) bound to 2 mM nAChR agonist sites. Ionic strength was varied by
titration of NaCl into 10 mM Hepes, D2O as described in Materials and
Methods. Error bars represent mean 6 SE (n ¼ 3). (C) The electrostatic
potential at each ionic strength was calculated as described in Materials and
Methods for free NBD-5-AC (s) and for bound NBD-5-AC (h). Errors
were calculated by propagation of error from mean 6 SE of the energy
transfer rates. The change in potential with respect to ionic strength was
ﬁtted to Eq. 3 (lines).
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proadifen (Fig. 5 B), which stabilizes the desensitized state
and shows a higher amplitude for the fast component at all
ionic strengths.
The ﬁrst rate terms of three-exponential ﬁts (Eq. 4), k1 (see
inset in Fig. 5 A), are plotted versus ionic strength in Fig. 5 C
for the data in the presence of proadifen (Fig. 5 B) and for
data in the absence of proadifen collected at higher DC6C
concentrations; the rates change 1.5- to 2-fold from low to
physiological ionic strength. Fits to the Debye-Hu¨ckel equa-
tion (Eq. 5; see also Eq. 6 in the accompanying paper,
Meltzer et al. (13)) were used to extract the effective charge
number (z) and mean distance of closest approach (r).
Agonist association to the nAChR in the absence of
proadifen was characterized by a charge distribution of z ¼
1.6 and r ¼ 7.6 A˚; in the presence of proadifen, z ¼ 2.4
and r ¼ 8.1 A˚. The effective electrostatic potential that
inﬂuences agonist association represents ;2 acidic residues
in proximity to the agonist binding sites. This result differs
from the Debye-Hu¨ckel analysis of potentials derived from
DEFET measurements that indicate only0.7 charges over a
smaller distribution.
Electrostatic potential at the AChE active site cleft
The local potential near the cleft to the AChE active site was
measured experimentally by determining the inﬂuence of the
local potential on the distribution of the Tb31-chelates near
the ﬂuorescent AChE inhibitor decidium. Because AChE is
soluble and scatters less light than the AChR-rich vesicles, we
could carry out experiments by titration of the ligand into
high, 10–20mMAChE concentrations, as illustrated in Fig. 6.
Tb31 decay rates, kobs, from titrations of free decidium into
low ionic strength buffer are plotted in Fig. 6 A and the
DEFET rates, k12 , k
0
2, and k

2 , determined from the slopes.
The slopes were steepest for Tb and shallowest for Tb1,
consistent with the presence of a positive potential at the bis-
cationic decidium. The DEFET rates, kx2, and corresponding
potentials for free decidium are given in Table 3; increasing
the ionic strength to physiological levels decreases the
potential from 114 to16 mV.
FIGURE 5 Association kinetics of DC6C binding to the nAChR. DC6C
binding was measured by rapidly mixing 400 nM DC6C with an equal
volume of 40 nM nAChR binding sites as described in Materials and
Methods in the absence (A) or presence (B) of 10 mM proadifen. NaCl
concentrations were 1, 12.5, 25, 50, 100, 250, and 400 mM. Higher NaCl
concentrations shift the association curves downward and to the right in both
experiments. Each kinetic trace was ﬁtted to the three-exponential equation
(Eq. 4); the inset shows ﬁts for 1, 50, and 400 mM NaCl from panel A. The
initial rates of association, k1, in the presence of proadifen (s, from panel B),
or the absence of proadifen (,, from separate data collected using 200 nM
nAChR and 2 mMDC6C) were plotted versus ionic strength (C) and ﬁtted to
the Debye-Hu¨ckel equation (Eq. 5).
FIGURE 6 Energy transfer from Tb31-chelates to decidium and to the
decidium-AChE complex. (A) Decidium was titrated into 8 mM Tb1 (:),
Tb0 (d), or Tb (;) in 10 mM Tris buffer and the luminescent decay rate,
kobs, determined at each concentration. (B) Decidium was titrated into
solutions of 20 mM AChE with 4 mM Tb31-chelate in either 10 mM Tris
buffer (n, s, ,) or in 40 mM MgCl2, 100 mM NaCl, 10 mM Tris (:, d,
;). The decay rates are plotted for titrations into Tb1 (n,:), Tb0 (s, d),
and Tb (,,;). The solid lines show the best linear ﬁts; the slopes equal kx2 .
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Energy transfer measurements were performed similarly
to AChE-bound decidium (Fig. 6 B, Table 3). The steepest
slopes, and largest k2 values, are for the positive chelate,
Tb1, indicative of a negative potential. This pattern of slopes
is similar in high and low ionic strength, but the changes in
slope were smaller in higher ionic strength, which reﬂects a
smaller negative potential. The energy transfer from Tb0, k02,
decreases by 50% from free decidium to AChE-bound
decidium. This change reﬂects the relative steric accessibility
of decidium upon binding and shows that the acceptor ﬂuor-
ophore remains largely solvent exposed, consistent with the
bound structure (Fig. 1 B). In low ionic strength conditions,
the data indicate in a local potential of 33 mV that
decreases to 14 mV in high ionic strength conditions.
To determine whether the electrostatic ﬁeld computed by
Poisson Boltzmann continuum electrostatics agreed with
these measurements, we used the computed potential to
determine the expected kx2 values by numerical integration,
using the methods presented in the accompanying article
(14), and further used the ratio of those values to calculate a
local potential. This value could then be compared directly to
the voltages determined from the ratio of measured values.
Although the integrated kx2 values differ from the measured
values by up to fourfold (see Table 3), the resultant potentials
agree with the measured potentials within 30%. In addition,
the change in computed k02 from free to bound decidium is
50%, which agrees with the measured change in k02.
DISCUSSION
Protein-cation interactions are stabilized through electro-
static interactions, often by formally neutral groups such as
backbone carbonyls in the selectivity ﬁlters of voltage-gated
potassium channels (43) or aromatic ring p-electrons in the
binding pocket of the nAChR (10). In addition, surface
charge distributions may stabilize cationic ligand binding by
enhancing association kinetics. We utilized DEFET mea-
surements to determine whether long-range electrostatic
interactions inﬂuence the binding afﬁnity and association
kinetics of ACh to the nAChR. We found that ACh binding
to the ag- and ad-sites of the nAChR are stabilized by
1 and 0.3 kcal/mol, respectively, in physiological ionic
strength (see calculation below). Electrostatic attraction
increases the association rate to a corresponding extent with
no change in the dissociation rates (8). Ionic strength screens
the inﬂuence of the charge density in the vicinity of the
binding sites. The experimental results were largely consis-
tent with the predictions based on the Poisson-Boltzmann
continuum electrostatic calculations. Thus, long-range elec-
trostatic attraction constitutes a small but measurable com-
ponent of ACh binding.
Electrostatics of nAChR agonist binding sites
We utilized the DEFET technique to measure surface
electrostatic potentials because this method provides a direct
comparison of three chelates that vary in charge but are
nearly isosteric and have nearly identical optical properties.
As DEFET donors, they can be compared directly with each
other without concern for differences in solubility, protein
interaction, reactivity, or chemical composition. The change
in DEFET rates with charge directly reﬂects the change in
local concentration due to long-range electrostatic interac-
tions rather than short-range interactions such as van der
Waals interactions, ion-pair formation, or dehydration. A
second, distinct advantage of the DEFET approach is that the
second order rate constants, kx2, can be computed by in-
tegration of the accessible volume surrounding the acceptor
and include the inﬂuence of electrostatic interactions (15).
Thereby, DEFET data can be compared directly with the
results from standard computations, such as continuum
Poisson-Boltzmann electrostatics, to provide a cross-check
between electrostatic computation and experiment.
TABLE 3 Energy transfer and potential determined near decidium and AChE
I Experimental k2 (mM
1 s1)* c
mM k12 k
0
2 k

2 mV
y
Free decidium 4, 13z 30 6 2 (2) 52.8 6 0.1 (2) 89 6 5 (2) 13.9 6 1.4
Free decidium 230 38 6 1 (2) 49 6 4 (2) 63 6 2.7 (2) 6.3 6 0.9
AChE 1 decidium 9, 13z 122 6 55 (2) 28 6 3 (2) 8.2 6 2.7 (2) 33 6 10
AChE 1 decidium 230 43 6 2 (2) 23.4 6 0.3 (2) 13.6 6 3.5 (3) 14 6 5
Computed k2 (mM
1 s1)§
k12 k
0
2 k2

Free decidium 20 8 14.9 18.4 16
AChE 1 decidium 20 46 7.3 1.7 42
AChE 1 decidium 300 12 7.3 4.9 11
*Experimental k2
x values were determined from (n) serial decidium titrations, carried out essentially as shown in Fig. 6, at the indicated ionic strengths.
Titrations in the presence of 10 or 20 mM AChE spanned 0–4 mM decidium; in the absence of AChE, titrations were to 10 mM decidium.
yLocal potentials were calculated from experimental or computed k2
x as described in Materials and Methods.
zData were combined from two experiments at different ionic strengths.
§Computed kx2 values were determined from the structure of decidium itself or as bound to AChE as described in Materials and Methods.
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The data show the presence of small negative potentials of
14 and 42 mV for the two agonist sites, at physiological
ionic strength. These values are not strikingly different from
the data of Addona et al. (6) who determined a 15 mV
potential using EPR after reacting a spin label at the agonist
sites. In contrast, Stauffer and Karlin (5) determined a
potential of80 mV from the reactivity of variously charged
methanethiosulfonate compounds with the reduced disulﬁde
of the agonist site. However, their value is for zero ionic
strength and, therefore, not inconsistent with the low ionic
strength value 60 mV determined here for the ag-site. In
addition, the reduced cysteines may themselves have con-
tributed to the measured potentials
The negative potentials contribute to larger binding energies
for theag- andad-sites by1 and0.3 kcal/mol, respectively
(DG ¼ zFc). The greater stabilization at the ag-site is
consistent with the larger number of negative charges in the
vicinity of the binding site supplied by the g-subunit.
Examination of the homology structure used in the computa-
tions in this article revealed 21 acidic and 16 basic residues
within 20 A˚ of the NBD-5-AC quaternary ammonium at the
ag-binding site, and 17 acidic and 15 basic residues at the ad-
binding site. Although several charged residues are in loops F,
which do not have a structural basis in the AChBP for their
conformation, the difference in charge numbers are consistent
with the differences in the measured potentials.
Despite the stronger, long-range electrostatic interaction
at the ag-site, the desensitized state of the nAChR displays
threefold higher afﬁnity at the ad-site for ACh and for its
ﬂuorescent analog DC6C (8). Differences in agonist afﬁnity
between the two sites have been ascribed to gK34, gF172,
gE57 and gC115 for the mouse nAChR (44), but the ﬁrst
two residues appear to primarily affect afﬁnity in the resting
state, rather than in the desensitized state, and the second
two residues do not involve charge changes. Given the
uncertainties in modeling loops F of the binding site
structures, we cannot exclude other direct or indirect de-
terminants of afﬁnity differences. Nevertheless, we com-
puted the Poisson-Boltzmann electrostatic potential within
the binding pocket at the site of the quaternary ammonium
in the absence of ligand, on the homology model at 300 mM
ionic strength. This calculation shows a stronger negative
potential in the ad-site,87 mV compared with42 mV in
the ag-site (42), that may partly account for the higher
afﬁnity of the ad-site. When the loop-F charged residues
(g161–176, d164–182) were excluded from the computa-
tion, the ad-site potential was 84 mV and the ag-site
became 33 mV. In this model, the g F-loop residues had a
larger effect on the quaternary ammonium binding site
potential, but the inﬂuence of loop-F residues was inade-
quate to explain the difference in potentials at the ad- and
ag-binding sites. Thus, although ag-site binding has a
larger, long-range electrostatic stabilization, ad-site bind-
ing is preferentially stabilized by shorter-range electrostatic
potentials.
Electrostatic effects on nAChR binding kinetics
The fastest component of DC6C binding kinetics reﬂects
diffusion-limited association with the desensitized state of
the receptor (7,8,45,46). If long-range electrostatic attraction
constitutes a signiﬁcant mechanism, this rate of binding
should be inﬂuenced by ionic strength, and the extent towhich
ionic strengthmoderates thekinetics should reﬂect the number
and disposition of charged residues (38). The data show a
twofold change in the association rate with ionic strength
increased up to physiological conditions. This change is rea-
sonably consistent with the observed changes in k12 , relative
to k02, from low to high ionic strength. The kinetic data did
not distinguish between the ag- and ad-binding sites, but the
association rates are similar for the two sites (8) in phys-
iological ionic strength. Nonetheless, it is possible that differ-
ences in association rates were missed at low ionic strength
conditions and the reported rates reﬂect an average rate of
association.
The change in kinetic rate was analyzed using a Debye-
Hu¨ckel equation. Increased ionic strength also decreased the
potentials measured by DEFET and this change was likewise
analyzed by a Debye-Hu¨ckel equation. The results of these
analyses are compared in Table 4. For NBD-5-AC itself, we
obtained a small charge and a radius of 4.4 A˚ that likely
reﬂect the distance of the NBD ﬂuorophore from the
quaternary ammonium (see Fig. 1). For the nAChR agonist
sites, the results differ a good deal, indicating from 0.7
charges to 2.4. Fitting to the Debye-Hu¨ckel formulas may
be imprecise because the ﬁtted parameters are correlated,
making it difﬁcult to determine either parameter precisely. In
addition, most of the dependency that deﬁnes the parameters
occurs at low ionic strength where experimental error was
larger likely because it is more difﬁcult to control pH and
ionic conditions.
Comparison of experimental and computed
electrostatic potentials
The experimental results on the nAChR agonist sites and on
AChE were consistent with the DEFET results calculated on
TABLE 4 Charge distribution at ACh binding sites from ionic
strength perturbation
Measurement Charge (z) r (A˚)*
NBD-5-AC DEFET 0.13 4.4
nAChR DEFETy 0.7 6 0.2 3.1 6 0.7
nAChR, kinetics - Pro§ 1.6 7.6
nAChR, kinetics 1 Pro§ 2.4 8.1
AChEz 9 13
*Mean distance of closest approach of probe to the countercharges.
yDEFET experiments with NBD-5-AC bound to nAChR in increasing
NaCl (Fig. 4).
§Rapid binding of DCC measured with stopped ﬂow (Fig. 5).
zCharge distribution at the AChE active site from Nolte et al. (38) presented
for comparison.
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the basis of computed Poisson-Boltzmann potentials and
numerical integration of DEFET rates, except for the data at
the ad-site. Observed kx2 values were higher than calculated
kx2 values in all cases, however, as discussed in Meltzer et al.
(14), this was likely because the numerical integration is
sensitive to the structure of the complex, to the assigned
chelate radius, and to the position of the acceptor dipole. For
these calculations, it was assumed that DEFET occurs to the
nearest atom of the acceptor ﬂuorophore. It was possible to
obtain larger calculated kx2 values by assigning a smaller
chelate radius. A possible source of the discrepancy in raw kx2
values is other mechanisms of energy transfer, such as
charge transfer (17,47) that may have been observed ex-
perimentally, but are not Fo¨rster energy transfer mechanisms
and would not appear in the calculation.
By comparing the voltages on the basis of experimental
and computed kx2 values, we obtain good agreement for free
NBD-5AC and for free decidium. This suggests that the
algorithm is sound for computing potentials. As discussed
(14), most computational and experimental systematic errors
will vary similarly for the three kx2 values (42) and cancel in
the voltage calculation. For bound NBD-5AC, the discrep-
ancies observed (Table 2) may arise from the ligand binding
models as there is no experimental structure for bound NBD-
5AC, although the modeling was apparently unambiguous.
In the context of decidium bound to AChE, where the
computation was based on a crystal structure, we observed
good agreement for all aspects of the measurements.
The electrostatic potential at the AChE
active site entrance
The role of the electrostatic potential in attracting ACh to the
active site of AChE has been extensively characterized and
serves as a benchmark for understanding electrostatic effects
on ligand association. The experimental results were consis-
tent with the expected values computed from the kx2 values,
based on the potential computed by continuum Poisson-
Boltzmann electrostatics in UHBD. The experimental and
computed values agreed to within 30% and this discrepancy
was consistent for free decidium, AChE-bound decidium in
low ionic strength, and AChE-bound decidium in high ionic
strength buffer. The better overall consistency may arise
because the crystal structure for bound decidium provides a
better basis for the computational estimate than computer-
docked ligand-receptor structures. Another possible source of
discrepancies between experimental and computational de-
terminations of energy transfer rates and local potentials is an
additionalmode(s) of Tb31 chelate deexcitation by collisional
quenching or electron transfer that is not accounted for in the
computational simulations of dipolar energy transfer (47).
Nevertheless, the substantial agreement between the exper-
imental and computational results suggests that continuum
electrostatic calculations provide a sound basis for determin-
ing long-range electrostatic interactions in this instance.
We did not compute the potential in the absence of ligand
to gauge the long-term electrostatics, as this has been
characterized thoroughly by others (2,4,48). Nonetheless, the
fourfold change in kx2 from neutral to positive, at low ionic
strength is similar to the sixfold change seen in rates com-
puted from Brownian dynamics simulations of the associ-
ation rate of AChE (3) at zero ionic strength. The change in
kx2 values with charge at high ionic strength, about twofold, is
also similar to Brownian dynamics simulations and with the
observed changes in rates of binding and reaction seen in
charge-mutated AChE (4).
CONCLUSIONS
We have determined the contribution of long-range electro-
statics to the energy of binding to the nAChR agonist binding
sites to be0.3 and1 kcal/mol at the ad- and ag-sites. We
further conclude that the higher desensitized state afﬁnity of
agonists to the ad-site may be due to short-range electrostatic
stabilization at the quaternary ammonium. The experiments
on AChE are consistent with previous characterization of
the electrostatic properties of this enzyme and its effect on
enzymatic activity and the rate of binding.
The overall consistency between the potentials determined
from experimental and calculated DEFET rates for AChE
and, to a lesser extent, for the nAChR agonist sites, differs
from the larger, twofold discrepancies observed for the
channel (14). Computation of electrostatics in the conﬁnes of
a narrow channel where the channel dimensions approach that
of the Debye length of the solvent have been argued to over-
estimate the screening effect of ions (20) because the channel
dimensions partly exclude the presence of counterions. How-
ever, in that case, it would suggest that computation would
underestimate the effective potential and its effect onDEFET,
especially at high ionic strength. Instead the computed po-
tentials overestimated the experimentally observed potentials
(14), and in both cases, ionic strength had substantial effects
on the potential. Lack of screening within the vestibule of the
channel does not explain these effects. The source of the dis-
crepancy, therefore, remains to be resolved.
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